BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 28279193)

  • 1. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; Coccè V; Bonomi A; Buccarelli M; Pascucci L; Alessandri G; Pessina A; Ricci-Vitiani L; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2017 Mar; 8(1):53. PubMed ID: 28279193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.
    Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; De Pascalis I; Coccè V; Bonomi A; Pascucci L; Alessandri G; Pessina A; Falchetti ML; Pallini R
    Stem Cell Res Ther; 2015 Oct; 6():194. PubMed ID: 26445228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
    Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
    Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?
    Clavreul A; Pourbaghi-Masouleh M; Roger E; Lautram N; Montero-Menei CN; Menei P
    J Exp Clin Cancer Res; 2017 Sep; 36(1):135. PubMed ID: 28962658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionizing radiation augments glioma tropism of mesenchymal stem cells.
    Thomas JG; Parker Kerrigan BC; Hossain A; Gumin J; Shinojima N; Nwajei F; Ezhilarasan R; Love P; Sulman EP; Lang FF
    J Neurosurg; 2018 Jan; 128(1):287-295. PubMed ID: 28362237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.
    Hata N; Shinojima N; Gumin J; Yong R; Marini F; Andreeff M; Lang FF
    Neurosurgery; 2010 Jan; 66(1):144-56; discussion 156-7. PubMed ID: 20023545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.
    Gao Y; Zhou Z; Lu S; Huang X; Zhang C; Jiang R; Yao A; Sun B; Wang X
    Stem Cells; 2016 Apr; 34(4):1112-22. PubMed ID: 26763650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESI-MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts.
    Wildburger NC; Wood PL; Gumin J; Lichti CF; Emmett MR; Lang FF; Nilsson CL
    J Proteome Res; 2015 Jun; 14(6):2511-9. PubMed ID: 25880480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.
    Pessina A; Bonomi A; Coccè V; Invernici G; Navone S; Cavicchini L; Sisto F; Ferrari M; Viganò L; Locatelli A; Ciusani E; Cappelletti G; Cartelli D; Arnaldo C; Parati E; Marfia G; Pallini R; Falchetti ML; Alessandri G
    PLoS One; 2011; 6(12):e28321. PubMed ID: 22205945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.
    Shimizu Y; Gumin J; Gao F; Hossain A; Shpall EJ; Kondo A; Parker Kerrigan BC; Yang J; Ledbetter D; Fueyo J; Gomez-Manzano C; Lang FF
    J Neurosurg; 2022 Mar; 136(3):757-767. PubMed ID: 34450587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.
    Pessina A; Coccè V; Pascucci L; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Crovace A; Falchetti ML; Zicari S; Caruso A; Navone S; Marfia G; Benetti A; Ceccarelli P; Parati E; Alessandri G
    Br J Haematol; 2013 Mar; 160(6):766-78. PubMed ID: 23293837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts.
    Zhu Y; Cheng M; Yang Z; Zeng CY; Chen J; Xie Y; Luo SW; Zhang KH; Zhou SF; Lu NH
    Drug Des Devel Ther; 2014; 8():2449-62. PubMed ID: 25525335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glioblastoma cell invasion by hsa-miR-145-5p and hsa-miR-31-5p co-overexpression in human mesenchymal stem cells.
    Kurogi R; Nakamizo A; Suzuki SO; Mizoguchi M; Yoshimoto K; Amano T; Amemiya T; Takagishi S; Iihara K
    J Neurosurg; 2018 Mar; 130(1):44-55. PubMed ID: 29521593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.
    Cao M; Mao J; Duan X; Lu L; Zhang F; Lin B; Chen M; Zheng C; Zhang X; Shen J
    Int J Cancer; 2018 Mar; 142(5):1033-1046. PubMed ID: 29047121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines.
    Bonomi A; Ghezzi E; Pascucci L; Aralla M; Ceserani V; Pettinari L; Coccè V; Guercio A; Alessandri G; Parati E; Brini AT; Zeira O; Pessina A
    Vet J; 2017 May; 223():41-47. PubMed ID: 28671070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tropism of mesenchymal stem cell toward CD133
    Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S
    Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo magnetic resonance imaging of cell tropism, trafficking mechanism, and therapeutic impact of human mesenchymal stem cells in a murine glioma model.
    Chien LY; Hsiao JK; Hsu SC; Yao M; Lu CW; Liu HM; Chen YC; Yang CS; Huang DM
    Biomaterials; 2011 Apr; 32(12):3275-84. PubMed ID: 21295344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.
    Hossain A; Gumin J; Gao F; Figueroa J; Shinojima N; Takezaki T; Priebe W; Villarreal D; Kang SG; Joyce C; Sulman E; Wang Q; Marini FC; Andreeff M; Colman H; Lang FF
    Stem Cells; 2015 Aug; 33(8):2400-15. PubMed ID: 25966666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.